No Data
No Data
Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
7 Children Given Bluebird's Skysona Developed Blood Cancer: Study
Bluebird Bio's Skysona Led to Seven Cases of Blood Cancer in Gene Therapy Trials
J.P. Morgan Maintains Bluebird Bio(BLUE.US) With Hold Rating
Top 10 Most Shorted Stocks on Wall Street
Bluebird Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
I Am 102927471 :